Home
Our Experts
Become an Expert
Ask A Question
Ask A Question
The * denotes a required field.
Ask A Question
Your Name
*
Email
*
Job Title
Topic
Cardiac Safety
Drug Delivery Technologies
Imaging
Subject
Question
*
Archives
Select Month
February 2010 (2)
January 2010 (6)
October 2009 (4)
September 2009 (2)
August 2009 (2)
July 2009 (4)
April 2009 (2)
Our Experts
Boaz Mendzelevski, MD
David M. Oakley, R.Ph., Ph.D.
Richard Walovitch, Ph.D.
Our Current Topics
Cardiac Safety
Drug Delivery Technologies
Imaging
Recent Questions
What advantages do microemulsion formulations offer specifically for topical and transdermal drug delivery?...
What’s your take on the emergence of chronotherapeutic drug delivery systems, which control drug release according to circadian rhythms and the timing of symptoms? Does this technology offer potential benefit in treating chronic diseases such as ulcers, asthma, and cardiovascular disease, which display time-dependent symptoms?...
Are there any ways to ameliorate the cardiac risks of a drug in development, if such risks are detected early enough? Is it possible to “rescue” a drug that exhibits those risks in the early clinical stages? Or should the developer just move on?...
What are the prospects for the expanded use of biomarkers in clinical trials to indicate cardiac risks? Are there any accepted biomarkers for cardiac risk at present? What is FDA’s stance on the use of these biomarkers as part of the submission for a drug?...
Do you see a discernable increase in demand for formulation development services, particularly in active preclinical formulations where it is often more difficult due to higher dosage levels?...
How much promise do new technologies exploring oral insulin analogues – many just entering human testing – have in diabetes drug delivery? Can the traditional hurdles in oral administration be overcome?...
What are the one or two, in your opinion, most promising novel imaging techniques emerging in Phase I and II studies, and which therapeutic areas do they have the greatest potential?...
